Securities code: 002118 Securities abbreviation: Zixin Pharmaceutical Announcement No.: 2019-030
The company and all members of the board of directors ensure that the content of the information disclosure is true, accurate and complete, and there are no false records, misleading statements or major omissions.
Special reminder:
1. The total number of shares lifted from restricted shares is 254,777,062 (the first 127,388,531 shares of ex-rights, and 254,777,062 shares after ex-rights on October 21, 2016), accounting for 19.89% of the company's total share capital as of April 30, 2019.
2. The restricted shares that have been lifted this time are listed on April 30, 2019.
3. The number of unrestricted shares in the company's total share capital after the lifting of restrictions is 254,777,062 shares.
1. Basic overview of this non-public restricted shares
On November 2, 2015, Jilin Zixin Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") received the "Approval on Approval of the Private Issuance of Shares of Jilin Zixin Pharmaceutical Co., Ltd." (Securities Supervision License [2015] No. 2409) issued by the China Securities Regulatory Commission, approving the company to issue no more than 159,235,664 shares of RMB common shares to specific objects. The company actually issued 127,388,531 shares of RMB common shares to five specific objects. The above-mentioned new shares were listed on the Shenzhen Stock Exchange on April 29, 2016, and are circulating shares with limited sales conditions. The specific targets of this issuance, Shanghai Hongying Asset Management Co., Ltd., Beijing Fudehaobang Investment Center (Limited Partnership), Foshan Science and Technology Incubation Partnership (Limited Partnership), natural persons Zhong Guilan and Guo Hua, are all 36 months from the date of the issuance, and the estimated listing and circulation time is April 30, 2019.
On October 14, 2016, the company issued the "Announcement on the Implementation of Equity Distribution in 2016", which is based on the company's total share capital of 640,379,913 shares on June 30, 2016, and will use the capital reserve fund to transfer 10 shares to all shareholders for every 10 shares, with a total increase of 640,379,913 shares. After the capital reserve is converted to increase capital, the company's total share capital will increase to 1,280,759,826 shares.
2. The performance of the shareholders who applied to lift the restricted shares in the stock
1. The restricted sales commitments and performances made by the shareholders of the restricted shares in the stock
2. As of the date of disclosure of this announcement, the shareholders who applied to lift the restricted shares in the stock have strictly fulfilled the above commitments, and there is no situation where the relevant commitments have not been fulfilled that affect the listing and circulation of this restricted shares.
3. Except for the above commitments, the above shareholders have no new relevant commitments.
3. Non-operational occupation of listed funds and illegal guarantees
As of the date of disclosure of this announcement, the shareholders who applied to lift the restriction on shares did not occupy the company's funds in non-operational occupation, and the company did not have any illegal guarantees for them.
4. The listing and circulation arrangements for the lifting of the restricted shares
1. The date of listing and circulation of the restricted shares is April 30, 2019
2. The total number of listed and circulated shares is 254,777,062 shares, accounting for 19.89% of the total number of shares of the company. The number of shareholders who lifted the restricted shares this time is 5.
3. The situation of the release of the restricted shares and the listing and circulation of the shares is as follows:
5. The capital change structure table before and after the release of the restricted shares
6. Reference documents
1, the application form for the restricted shares
2, the application form for the restricted shares
3, the issuer share structure table
4, the detailed data table for the restricted shares
5, the confirmation for the change of shares
1, hereby announced.
Jilin Zixin Pharmaceutical Co., Ltd.
Board of Directors
April 24, 2019
